{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fiambio.simplecast.com%2Fepisodes%2Fbiotechs-finest-hour-redux-paDhD2dY","width":444,"version":"1.0","type":"rich","title":"Biotech's Finest Hour (Redux)","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9b3967de-d938-42f2-b54e-99b29c007c9b/edf95499-0c7d-4519-8809-c86b3b8795c1/bio-podcast-logo-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/67c355ee-1a3a-4815-986b-4be394acc3e6\" height=\"200\" width=\"100%\" title=\"Biotech&apos;s Finest Hour (Redux)\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"As the world waits for biotechnology to deliver COVID-19 treatments and a vaccine, Ambassador Deborah Birx tells BIO’s scientists: “Expectations are high because you’ve delivered for us before and I know that you can deliver for us again.” BIO chairman Jeremy Levin, a biotech pioneer, explains how the industry will rise to meet this moment.\n\nHosted by Jim Greenwood. "}